Letters to the Editor
Fish oil supplementation in patients with and without systemic lupus erythematosus: targeting pro-inflammatory and pro-resolving lipid mediators
M.Y. Choi1, N.R. Cook2, G. Kotler3, C.N. Serhan4, R. Tatituri5, K.H. Costenbader6
- Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, and Division of Rheumatology, Cumming School of Medicine, University of Calgary, Alberta, Canada. may.choi@ucalgary.ca
- Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Division of Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; and Center for Lipid Metabolomics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA.
- Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Division of Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; and Center for Lipid Metabolomics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA.
- Department of Anesthesia, Perioperative and Pain Medicine, Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital-Harvard Medical School, Boston, MA, USA.
- Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
- Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
CER15674
2022 Vol.40, N°11
PI 2196, PF 2197
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 35894061 [PubMed]
Received: 13/03/2022
Accepted : 23/05/2022
In Press: 21/07/2022
Published: 05/11/2022
